GlassScriptPhysician profile
Jenny W Rush
NPI 1699235150
$426.71
in general payments reported to CMS, 2019-2025
10 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $131 · 2024: $78.35 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $101.86 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $67.52 | 2025 | Myfembree |
| Daiichi Sankyo INC. | $63.56 | 2023-2025 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $47.87 | 2023-2025 | |
| Medtronic, INC. | $38.87 | 2023 | Ligasure |
| Channel Medsystems, INC. | $27.93 | 2024 | |
| Organon LLC | $25.80 | 2024-2025 | Nexplanon |
| Exeltis, USA INC. | $21.78 | 2025 | Slynd |
| Novo Nordisk INC | $17.89 | 2023 | Wegovy |
| Agile Therapeutics, INC. | $13.63 | 2023 | Twirla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Rush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.